Ovianta Brand Audit

EXECUTIVE SUMMARY

General Strategic Reading

Ovianta is a solid healthtech startup in product but almost invisible in marketing. Founded in 2024 as a spinoff of the UAB and backed by First Drop and Itnig, it offers a well-built and validated AI voice agent (180+ deployed agents, 67% of calls handled by AI). Its real advantage is being EU-native with first-class GDPR, a genuine differentiator compared to American competitors like Prosper AI or Hyro. However, its weakness is severe: zero public portfolio, nonexistent marketing, dormant LinkedIn, and no visible testimonials. The product competes, the communication does not. The window of opportunity is now (2026): if it executes aggressive growth marketing in the next 6 months, it can capture the European market before American giants localize their offer. Without that pivot, the risk is invisibility followed by irrelevance or defensive acquisition.

FULL REPORT

General Information and Corporate Identity

Official Name: Ovianta Technologies SL Website: https://ovianta.com/es/ App: https://app.ovianta.com Active Social Media:

• LinkedIn: linkedin.com/company/ovianta

Slogan / Claim:

• “Reclaim your team’s time with an AI voice agent that works 24/7”
• “Put administrative tasks on autopilot and your team in patient mode”

Declared Mission: Automate routine administrative tasks of clinics and hospitals (calls, scheduling, follow-up) so the human team focuses on the patient.

Declared Values: Operational efficiency, regulatory compliance (GDPR/LOPDGDD), patient experience, frictionless technological accessibility.

History / Context: Founded in 2024 in Barcelona. Spinoff of the Autonomous University of Barcelona (UAB), with participation from the CERCA center (CVC). Backed by investors First Drop and Itnig (Catalan startup ecosystem). Technical team led by Rubén Martín Pozo (7 years in tech, ex-CEO of previous startup) and Alejandro Quintans.

Business Type: B2B (SaaS for clinics and hospitals).

Geographic Market: Based in Barcelona, Spain. Initial coverage Europe (Spain, Portugal, Italy due to multi-language capability). Expansion potential LATAM (less saturated market, same language).

Location: Barcelona, Calle de Sant Antoni Maria Claret 167, Horta-Guinardó, 08025.

Employees: ~15-20 people (inferred: early stage).

Value Proposition

UVP (Unique Value Proposition): “An AI voice agent that handles 100% of your clinic’s administrative calls 24 hours a day, schedules and reschedules appointments, fills your schedule automatically from waiting lists, and complies with GDPR from day one, without you having to change your current management software.”

Problem it solves:

• For clinics and hospitals: the team loses 2-3 FTE (full-time employees) on administrative calls. No-shows represent 15-20% empty capacity. SMS/email reminders are not enough.

Identified Differentiating Pillars:

1. 24/7 availability without voicemails or telephone “ping-pong”.
2. Integration with existing management software (no migration required).
3. Native GDPR + LOPDGDD (pseudonymized data, data centers only in EU).
4. Multi-language with in-call auto-detection (Spanish, English, Portuguese, Italian).
5. Fast implementation (1 week for a clinic).

Implicit Brand Promise: Reclaim human time for patient care, eliminating repetitive administrative burden.

What makes this brand different: Compared to American competition, Ovianta is born European with regulatory compliance as a structural advantage, not as an add-on. Compared to enterprise solutions, it is agile and accessible for medium clinics.

Product and Service Portfolio

Single Product (modular platform):

1. Automatic Scheduling: Patient calls, AI answers, schedules appointment, and integrates with management system.
2. Outbound Reminders: Automatic calls before the appointment; reschedules instantly if necessary.
3. Smart Waiting List Management: If there’s a cancellation, AI automatically contacts patients on waitlist to fill the gap.
4. Automated Campaigns (phone or WhatsApp): Post-visit follow-up, quality surveys, response collection.

Integrations:

• Standard Practice Management Software (PMS) via integration or API.
• Connection to cloud PBX/telephony via SIP or API.

Compliance:

• GDPR + LOPDGDD (Spain).
• Encryption in transit and at rest, PCI-DSS security.
• Languages: Spanish, English, Portuguese, Italian.

Business Model: Monthly SaaS subscription, no long-term commitment (month-to-month renewal). Payment via Stripe and SEPA direct debit.

Prices: Not published. Inferred: small clinics ~€300-500/month; medium ~€800-2,000/month; hospitals/groups tailored.

Sales Channels: Demo requested via form (HubSpot), direct sales.

Buyer Personas

Primary: Administrative Director / Clinic Manager (50-200 bed clinics)

• Profile: operational manager of private clinic or medium medical group.
• Pain: loses 2-3 FTEs to calls; no-shows = 15-20% empty capacity.
• Motivation: free up staff, fill schedule, reduce operational costs.
• Budget: €500-2,000/month (justifiable in staff savings).
• Decision: 2-4 weeks; needs to see clear ROI.
• Influencer: CTO/IT manager (integration).

Secondary: CEO/Founder of HealthTech Startup

• Profile: founder of virtual clinic or telehealth platform.
• Pain: needs to scale without adding staff.
• Motivation: scalability, efficiency.
• Budget: €500-1,500/month.
• Decision: fast, impulsive if they see traction in competitors.

Tertiary: CMO/Marketing Director of Hospital or Group

• Profile: head of operations/marketing in large hospital.
• Pain: automate 10,000+ reminder and follow-up calls/month.
• Motivation: efficiency at scale.
• Budget: €5,000-15,000/month (tailored).
• Decision: slow (6-12 months), requires proof of concept and CISO/compliance approval.

Analysis of Digital Presence and Social Media Content

Website (ovianta.com/es):

• Technology: Framer (SPA).
• SEO: weak (inferred 3/10); an SPA poorly indexes dynamic content.
• Content: minimalist (1 headline, 4 benefits, extensive FAQ, CTA demo).
• Lead magnet: none visible (opportunity: whitepaper, checklist).
• Trust signals: practically null. Home metrics (19,978 calls handled, 67% by AI, 180+ agents) but no cases or nominal testimonials.

LinkedIn:

• Followers: ~500-1,000 (inferred).
• Cadence: approximately 1 post/month (inferred, underutilized).
• Content: announcements, hiring, product news. Zero thought leadership.
• Internal Influencers: Rubén Martín Pozo (CEO), Alejandro Quintans.

Blog:

• Exists at ovianta.com/es/blog. Frequency and depth not confirmed (inferred low).

Other Channels (Instagram, X/TikTok):

• Minimal or no presence on B2C channels; consistent with B2B focus, but leaves educational reach formats unexploited.

Tone and Brand Voice

Detected Brand Personality: Professional, pragmatic, oriented towards operational efficiency. Approachable yet serious tone, typical of B2B healthcare software.

Tone by Channel:

• Web: clear, direct, focused on benefits (“reclaim your team’s time”).
• LinkedIn: institutional, announcements without authority narrative.

Recurring words and phrases: Automate, voice agent, 24/7, GDPR, patients, schedule, hassle-free, autopilot.

What this brand would never do (inferred): Sensationalist communication, medical promises, technical AI language without grounding in operational benefit. Its register is sober and trust-oriented.

Competitive Analysis

Prosper AI (USA) — prosper-ai

• Proposition: patient access + RCM (revenue cycle management) with AI voice.
• Strength: #1 documented brand in USA, 500+ clients, strong content.
• Weakness: expensive, US-centric, not GDPR-native.
• Differential vs. Ovianta: maturity and massive social proof; Ovianta wins in EU compliance.

Hyro — hyro.ai

• Proposition: healthcare enterprise conversational AI.
• Strength: enterprise-ready, pre-built workflows.
• Weakness: little EU presence, overkill for medium clinic.

Telnyx — telnyx

• Proposition: full-stack voice infrastructure (speech + model + telephony).
• Strength: carrier-grade, global, BAA in 20+ countries.
• Weakness: too much for a small clinic; not specialized.

Competitor Comparison Table

Strengths, Weaknesses, Opportunities, and Threats

Identified Strengths:

• Timing: healthcare AI voice grows ~37.79% annually (Gartner 2026).
• Academic spinoff (UAB) that brings credibility and talent.
• GDPR-first as differentiating DNA against USA competition.
• Technical team with experience (Rubén Martín, 7 years in tech).
• Validated product (180+ agents, 67% of calls handled by AI).
• Native multi-language (Ibero-American advantage).
• Simple integration via API with any PMS.

Weaknesses or Gaps:

• Unknown brand outside Barcelona.
• Zero public portfolio, zero nominal testimonials.
• Null marketing (LinkedIn, blog, content strategy absent).
• No thought leadership from founding team.
• Modest initial investment compared to competitors with large rounds.
• Non-transparent pricing.

Concrete Opportunities (prioritized by impact):

1. Positioning as “the European Prosper AI”: replicate their playbook (cases, webinars, SEO).
2. Aggressive content marketing: SEO blog (50+ posts on healthcare AI voice in Spanish).
3. High ROI specific verticals: dental clinics, gynecology, podiatry.
4. Partnerships with Spanish/LATAM PMS providers (native integration).
5. CEO Rubén Martín’s personal brand publishing weekly.
6. Sector reports (“AI Voice in Spanish clinics 2026”) as a lead magnet.

Risks or Environment Threats:

• Accelerated consolidation: Prosper, Hyro or Telnyx could localize or acquire.
• Commoditization: generic models (Claude, GPT, Gemini) improving voice.
• Clinical software incumbents natively integrating AI voice.
• Burn rate: early-stage without explosive traction = risk at 18-24 months.
• Silent churn: clinics pilot and don’t see clear ROI.

Strategic Recommendations for Agency or Freelancer

Quick wins (first 30 days):

• Publish 5 anonymized success cases with metrics (“dental clinic: -35% no-shows in 60 days”).
• Activate CEO on LinkedIn: 3 posts/week about healthcare AI.
• Add trust signals to the site (logos, testimonials, results data).

Medium-term priorities (90 days):

• Launch SEO blog (2 posts/week) on “automate clinic calls”, “healthcare AI voice GDPR”, “reduce no-shows AI”.
• Public webinar: “AI Voice in Spanish clinics 2026: GDPR + ROI” as a lead magnet.
• Freemium tier (e.g., 50 calls/month) for viral adoption in SME clinics.

Long-term initiatives:

• LATAM expansion (Mexico, Colombia, Chile) with es/pt localization.
• Vertical playbooks by specialty (dental, gynecology, podiatry).
• Affiliate program (commission for healthtech consultants).
• M&A Strategy: position as an attractive acquisition target.

CONCLUSION

Ovianta has a validated product and a genuine regulatory differentiator (GDPR-first), but its marketing is practically nonexistent. Without a strategic pivot, in 18 months it faces the risk of invisibility or defensive acquisition. The window of opportunity is now: executing content, success cases, and thought leadership in the next 6 months can consolidate the European market before American giants localize their offer. For a scientific marketing consultant, it is an ideal case to demonstrate expertise in regulated healthtech communication and B2B growth marketing.

Analysis generated: June 2026 Methodology: web scrape + competitive intelligence + market research Data confidence: medium (early-stage company, limited public information)